Improving care after hip fracture: the fracture? Think osteoporosis (FTOP) program

BMC Geriatrics

Table 2 Percent (n) of patients with osteoporosis pharmacotherapy within 6-months of discharge

	2008 (n=110)	2011 (n=97)
Taking OP medication by 6-months	75%	56%
Taking OP medication by 6-months	(82/110)	(54/97)
Initiated after involvement in FTOP^a	35%	30%
Initiated after involvement in FTOP^a	(39/110)	(29/97)
Taking at baseline	n = 44	N = 28
Discontinued treatment after baseline	n = 1	n = 3
Taking vitamin D supplement (≥800 IU) by 6-months^b	94%	93%
Taking vitamin D supplement (≥800 IU) by 6-months^b	(103/110)	(90/97)
Initiated after involvement in FTOP^c	36%	28%
Initiated after involvement in FTOP^c	(40/110)	(27/97)
Taking at baseline	n = 66	N = 65
Discontinued treatment after baseline	n = 3	n = 2
Taking calcium supplement (≥500 mg) by 6-months^b	93%	81%
Taking calcium supplement (≥500 mg) by 6-months^b	(102/110)	(79/97)
Initiated after involvement in FTOP^d	36%	26%
Initiated after involvement in FTOP^d	(40/110)	(25/97)
Taking at baseline	n = 66	60
Discontinued treatment after baseline	n = 4	n = 6

^aPatients were not previously taking osteoporosis medication. (OP = osteoporosis).
^bFor patients who were not contacted at 6-months (because they taking osteoporosis treatment at the 2-month assessment), the answer the provided regarding supplementation at 2-month assessment was used.
^cPatients not taking any vitamin D prior to FTOP.
^dPatients not taking any calcium prior to FTOP.

ISSN: 1471-2318